The Alliance for IP Media Solutions (AIMS) will mark a major milestone for Pro AV over IP at ISE 2026 with the official launch of Internet Protocol Me ...
Manufacturers capitalize on predictive-maintenance insights and regional production, navigating cost-sensitive and growth-driven segmentsDublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Linear Motion ...
At ISE 2026, Kiloview will present its next-generation IP media management solution, designed to simplify, visualize, and optimize AV-over-IP workflows, making complex systems more reliable and ...
Fit for purpose choices will always outperform trend driven ones. With the right orchestration layer in place, broadcasters ...
Last year, Geehy introduced the industry’s first dual-core Cortex-M52 real-time MCU, and has now followed up with the G32R430 ...
NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...
FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a ...
FDA assigned PDUFA target action date of July 7, 2026. If approved, atacicept would be the first B cell modulator targeting both BAFF and APRIL for IgAN. Atacicept received FDA Breakthrough Therapy ...
– Potential first approval of a menin inhibitor for the treatment of adult patients with relapsed or refractory AML with an NPM1 mutation – SAN DIEGO and TOKYO, June 01, 2025 (GLOBE NEWSWIRE) -- Kura ...
February 5th – second round fall deadline (as programs remain open) March 5th – third round fall deadline (as programs remain open) April 5th and beyond** – fourth round fall deadline (as programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results